Dominic Smethurst
Chief Medical Officer, Bicycle Therapeutics (United Kingdom).
Companies
- Corbus PharmaceuticalsChief Medical Officer Feb 29, 2024 to now1
- Bicycle Therapeutics (United Kingdom)Chief Medical Officer Aug 19, 2020 to Jan 5, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Corbus Pharmaceuticals CRBP89,790 shares3$405.9K at $4.52Mar 2, 2026
Bicycle Therapeutics (United Kingdom) BCYC36,699 shares4$127.0K at $3.46Jan 3, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 2, 2026Sold 6,097 shares at $8.30 of Corbus Pharmaceuticals3
- Feb 3, 2026Sold 3,285 shares at $8.09 of Corbus Pharmaceuticals5
- Jan 14, 2026Granted 28,365 shares of Corbus Pharmaceuticals6
- Mar 6, 2025Sold 6,393 shares at $6.78 of Corbus Pharmaceuticals7
- Jan 31, 2025Granted 27,200 shares of Corbus Pharmaceuticals8
- Feb 27, 2024Granted 50,000 shares of Corbus Pharmaceuticals9
- Jan 3, 2023Sold 1,801 shares at $29.06 of Bicycle Therapeutics (United Kingdom)4
- Jan 3, 2023Granted 17,500 shares of Bicycle Therapeutics (United Kingdom)4
- Jan 3, 2022Granted 15,000 shares of Bicycle Therapeutics (United Kingdom)10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 4, 2026
- 6SEC EDGARForm 4 filed Jan 16, 2026
- 7SEC EDGARForm 4 filed Mar 7, 2025
- 8SEC EDGARForm 4 filed Feb 4, 2025
- 9SEC EDGARForm 4 filed Feb 29, 2024
- 10SEC EDGARForm 4 filed Jan 5, 2022